 Anthony Gerber
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 11 | 2019 | 130 | 3.790 |
Why?
| | Glucocorticoids | 8 | 2016 | 532 | 1.910 |
Why?
| | Kruppel-Like Transcription Factors | 6 | 2017 | 61 | 1.620 |
Why?
| | Muscle, Smooth | 4 | 2019 | 144 | 1.600 |
Why?
| | Dexamethasone | 7 | 2019 | 317 | 1.540 |
Why?
| | Nuclear Proteins | 6 | 2017 | 591 | 1.480 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2019 | 1140 | 1.140 |
Why?
| | Airway Remodeling | 2 | 2017 | 57 | 0.950 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 4 | 2016 | 11 | 0.930 |
Why?
| | Asthma | 8 | 2017 | 2029 | 0.920 |
Why?
| | Gene Expression Regulation | 8 | 2017 | 2320 | 0.910 |
Why?
| | NF-kappa B | 4 | 2019 | 641 | 0.680 |
Why?
| | Transcription Factors | 3 | 2018 | 1528 | 0.660 |
Why?
| | Respiratory System | 2 | 2017 | 137 | 0.650 |
Why?
| | Bronchi | 3 | 2018 | 232 | 0.640 |
Why?
| | Transcription, Genetic | 5 | 2018 | 1313 | 0.610 |
Why?
| | Proline Oxidase | 2 | 2015 | 5 | 0.610 |
Why?
| | Hyperoxia | 1 | 2019 | 99 | 0.610 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1314 | 0.600 |
Why?
| | Response Elements | 2 | 2015 | 82 | 0.580 |
Why?
| | Phospholipase C delta | 1 | 2017 | 3 | 0.580 |
Why?
| | Airway Obstruction | 1 | 2019 | 168 | 0.560 |
Why?
| | Adrenal Cortex Hormones | 2 | 2018 | 497 | 0.550 |
Why?
| | Inflammation | 3 | 2019 | 2479 | 0.550 |
Why?
| | Transcription Factor RelA | 2 | 2016 | 82 | 0.540 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 349 | 0.520 |
Why?
| | Homeodomain Proteins | 2 | 2018 | 463 | 0.510 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.500 |
Why?
| | Triage | 1 | 2017 | 199 | 0.500 |
Why?
| | Machine Learning | 1 | 2017 | 316 | 0.460 |
Why?
| | Genes, Reporter | 2 | 2017 | 257 | 0.440 |
Why?
| | Epithelial Cells | 2 | 2016 | 951 | 0.430 |
Why?
| | Drug Discovery | 2 | 2016 | 123 | 0.430 |
Why?
| | Introns | 1 | 2014 | 227 | 0.420 |
Why?
| | Prednisolone | 1 | 2013 | 75 | 0.420 |
Why?
| | RNA, Messenger | 2 | 2019 | 2553 | 0.420 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 192 | 0.420 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 447 | 0.410 |
Why?
| | Gene Expression | 2 | 2016 | 1421 | 0.390 |
Why?
| | Cell Line | 6 | 2016 | 2637 | 0.390 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 386 | 0.380 |
Why?
| | Cytokines | 2 | 2016 | 1841 | 0.360 |
Why?
| | Bronchial Hyperreactivity | 1 | 2011 | 95 | 0.350 |
Why?
| | Signal Transduction | 8 | 2019 | 4513 | 0.350 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 916 | 0.350 |
Why?
| | Protein Binding | 5 | 2017 | 1890 | 0.310 |
Why?
| | Chromatin Immunoprecipitation | 4 | 2017 | 128 | 0.310 |
Why?
| | Vitamin D | 1 | 2011 | 341 | 0.310 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 2 | 2018 | 32 | 0.290 |
Why?
| | Cells, Cultured | 5 | 2019 | 3886 | 0.290 |
Why?
| | Transcriptional Activation | 3 | 2016 | 337 | 0.280 |
Why?
| | RNA Polymerase II | 4 | 2017 | 284 | 0.280 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 236 | 0.280 |
Why?
| | Enhancer Elements, Genetic | 2 | 2019 | 151 | 0.280 |
Why?
| | Humans | 28 | 2019 | 114674 | 0.260 |
Why?
| | Lung | 3 | 2017 | 3561 | 0.260 |
Why?
| | Binding Sites | 4 | 2017 | 1168 | 0.260 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2177 | 0.260 |
Why?
| | Systems Biology | 1 | 2006 | 54 | 0.250 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2017 | 1880 | 0.250 |
Why?
| | Promoter Regions, Genetic | 4 | 2017 | 1131 | 0.250 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 448 | 0.250 |
Why?
| | Lung Diseases | 2 | 2015 | 701 | 0.240 |
Why?
| | Base Sequence | 4 | 2017 | 2114 | 0.230 |
Why?
| | Diagnostic Imaging | 1 | 2006 | 275 | 0.220 |
Why?
| | Animals | 11 | 2019 | 31706 | 0.190 |
Why?
| | Primary Cell Culture | 2 | 2019 | 149 | 0.180 |
Why?
| | Gene Silencing | 2 | 2016 | 171 | 0.160 |
Why?
| | Mice | 6 | 2019 | 14869 | 0.150 |
Why?
| | Fluticasone | 1 | 2018 | 87 | 0.150 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 93 | 0.150 |
Why?
| | Mucins | 1 | 2018 | 61 | 0.150 |
Why?
| | Drug Resistance | 1 | 2018 | 158 | 0.150 |
Why?
| | Histidine Decarboxylase | 1 | 2017 | 5 | 0.150 |
Why?
| | Cellular Senescence | 1 | 2019 | 152 | 0.150 |
Why?
| | Microphthalmia-Associated Transcription Factor | 1 | 2017 | 14 | 0.150 |
Why?
| | GATA2 Transcription Factor | 1 | 2017 | 12 | 0.150 |
Why?
| | Regeneration | 1 | 2019 | 160 | 0.140 |
Why?
| | Hypertrophy | 1 | 2017 | 109 | 0.140 |
Why?
| | HEK293 Cells | 1 | 2019 | 591 | 0.140 |
Why?
| | Transduction, Genetic | 1 | 2017 | 113 | 0.140 |
Why?
| | Mast Cells | 1 | 2017 | 116 | 0.140 |
Why?
| | Trachea | 1 | 2018 | 224 | 0.140 |
Why?
| | Biological Therapy | 1 | 2017 | 26 | 0.140 |
Why?
| | Statistics as Topic | 1 | 2017 | 292 | 0.140 |
Why?
| | Infant, Newborn | 2 | 2019 | 5045 | 0.140 |
Why?
| | Feedback, Physiological | 1 | 2016 | 68 | 0.140 |
Why?
| | Adenoviridae | 1 | 2017 | 184 | 0.140 |
Why?
| | Lung Injury | 1 | 2019 | 198 | 0.130 |
Why?
| | Models, Biological | 4 | 2016 | 1620 | 0.130 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 251 | 0.130 |
Why?
| | Chromatin | 1 | 2019 | 428 | 0.130 |
Why?
| | Male | 9 | 2019 | 55589 | 0.130 |
Why?
| | Drug Monitoring | 1 | 2016 | 184 | 0.120 |
Why?
| | Mucin-5B | 1 | 2017 | 183 | 0.120 |
Why?
| | Consensus | 1 | 2017 | 537 | 0.120 |
Why?
| | Anaphylaxis | 1 | 2017 | 143 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2018 | 719 | 0.120 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 268 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 72 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 385 | 0.120 |
Why?
| | Administration, Inhalation | 1 | 2016 | 641 | 0.120 |
Why?
| | Mice, Inbred C57BL | 3 | 2015 | 4694 | 0.120 |
Why?
| | Muscle, Skeletal | 2 | 2015 | 1472 | 0.120 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2015 | 80 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 616 | 0.120 |
Why?
| | Congresses as Topic | 1 | 2016 | 195 | 0.120 |
Why?
| | RNA Interference | 1 | 2016 | 433 | 0.110 |
Why?
| | Female | 8 | 2018 | 59499 | 0.110 |
Why?
| | Pulmonary Surfactants | 1 | 2015 | 99 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 923 | 0.110 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 101 | 0.110 |
Why?
| | Blotting, Western | 1 | 2016 | 1147 | 0.110 |
Why?
| | Immunotherapy | 1 | 2017 | 474 | 0.110 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 228 | 0.100 |
Why?
| | Precision Medicine | 1 | 2016 | 337 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 439 | 0.100 |
Why?
| | Adenocarcinoma | 1 | 2018 | 795 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1518 | 0.100 |
Why?
| | Transcriptome | 1 | 2017 | 725 | 0.100 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 2710 | 0.100 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2017 | 505 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2017 | 2570 | 0.090 |
Why?
| | Disease Progression | 1 | 2017 | 2380 | 0.090 |
Why?
| | Ovalbumin | 1 | 2011 | 161 | 0.090 |
Why?
| | Fibroblasts | 1 | 2015 | 838 | 0.090 |
Why?
| | Algorithms | 1 | 2017 | 1468 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2785 | 0.090 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1262 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2763 | 0.090 |
Why?
| | Biomarkers | 2 | 2017 | 3408 | 0.080 |
Why?
| | Physicians | 1 | 2017 | 772 | 0.080 |
Why?
| | Caproates | 1 | 2009 | 4 | 0.080 |
Why?
| | Aurintricarboxylic Acid | 1 | 2009 | 4 | 0.080 |
Why?
| | Toluidines | 1 | 2009 | 6 | 0.080 |
Why?
| | Rosaniline Dyes | 1 | 2009 | 10 | 0.080 |
Why?
| | Lipid Metabolism | 1 | 2012 | 444 | 0.080 |
Why?
| | Anthracyclines | 1 | 2009 | 41 | 0.080 |
Why?
| | Adipogenesis | 1 | 2009 | 42 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 740 | 0.080 |
Why?
| | Biological Assay | 1 | 2009 | 112 | 0.080 |
Why?
| | Autonomic Nervous System | 2 | 2005 | 66 | 0.070 |
Why?
| | Fluorescent Dyes | 1 | 2009 | 301 | 0.070 |
Why?
| | Ligands | 1 | 2009 | 562 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2011 | 1949 | 0.060 |
Why?
| | Tobacco, Smokeless | 1 | 2005 | 9 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2017 | 535 | 0.060 |
Why?
| | Drug Therapy | 1 | 2005 | 76 | 0.060 |
Why?
| | Disease | 1 | 2005 | 85 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2011 | 2187 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2016 | 9088 | 0.050 |
Why?
| | Pulmonary Fibrosis | 1 | 2006 | 323 | 0.050 |
Why?
| | Environment | 1 | 2005 | 332 | 0.050 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2005 | 159 | 0.050 |
Why?
| | Nicotine | 1 | 2005 | 265 | 0.050 |
Why?
| | Exercise | 1 | 2012 | 1644 | 0.050 |
Why?
| | Young Adult | 1 | 2016 | 10466 | 0.050 |
Why?
| | Genetic Variation | 1 | 2005 | 870 | 0.040 |
Why?
| | Adolescent | 1 | 2016 | 17841 | 0.040 |
Why?
| | Th1 Cells | 1 | 2018 | 123 | 0.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2017 | 39 | 0.040 |
Why?
| | Smoking | 1 | 2005 | 1383 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 11 | 0.040 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 159 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 188 | 0.040 |
Why?
| | Formoterol Fumarate | 1 | 2016 | 7 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 117 | 0.030 |
Why?
| | I-kappa B Kinase | 1 | 2016 | 50 | 0.030 |
Why?
| | Budesonide | 1 | 2016 | 87 | 0.030 |
Why?
| | Middle Aged | 1 | 2016 | 26735 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 299 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2017 | 314 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 225 | 0.030 |
Why?
| | Canada | 1 | 2017 | 322 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 823 | 0.030 |
Why?
| | Eosinophils | 1 | 2017 | 278 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2017 | 366 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1842 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 935 | 0.030 |
Why?
| | DNA Methylation | 1 | 2017 | 495 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 668 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1342 | 0.030 |
Why?
| | Rats | 1 | 2019 | 4958 | 0.020 |
Why?
| | United States | 2 | 2017 | 12182 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3535 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 2796 | 0.020 |
Why?
| | Amino Acids | 1 | 2012 | 448 | 0.020 |
Why?
| | Homeostasis | 1 | 2012 | 573 | 0.020 |
Why?
| | Glucose | 1 | 2012 | 897 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9114 | 0.020 |
Why?
| | Biological Clocks | 1 | 2005 | 37 | 0.010 |
Why?
| | Tachycardia | 1 | 2005 | 50 | 0.010 |
Why?
| | Tumor Escape | 1 | 2005 | 35 | 0.010 |
Why?
| | Vagus Nerve | 1 | 2005 | 79 | 0.010 |
Why?
| | Melatonin | 1 | 2005 | 105 | 0.010 |
Why?
| | Th2 Cells | 1 | 2005 | 154 | 0.010 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 171 | 0.010 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2005 | 119 | 0.010 |
Why?
| | Life Style | 1 | 2005 | 430 | 0.010 |
Why?
| | Receptors, Nicotinic | 1 | 2005 | 274 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 2005 | 354 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2005 | 374 | 0.010 |
Why?
| | Child | 1 | 2018 | 18412 | 0.010 |
Why?
| | Anxiety | 1 | 2005 | 840 | 0.010 |
Why?
| | Hypertension | 1 | 2005 | 1056 | 0.010 |
Why?
| | Neoplasms | 1 | 2005 | 2097 | 0.010 |
Why?
|
|
Gerber's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|